Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1990-03-29
1992-12-22
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
A61K 3117
Patent
active
051735091
ABSTRACT:
A method is disclosed for the treatment of hypercalcemia in a patient, by administering to the patient an effective amount of suramin, or an active analogue thereof, for lowering calcium plasma levels in the patient. Human data shows a single course of treatment lowers plasma calcium levels to normal for three months.
REFERENCES:
H. Connerty et al., The American Journal of Clinical Pathology, vol. 45, No. 3 pp. 290-296 (Jun. 1965).
R. Klecker et al., Journal of Liquid Chromatography, 8(9), 1685-1696 (1985).
Stein et al., Journal of Clinical Oncology, vol. 7, No. 4 (Apr. 1989) pp. 499-508.
Jentsch et al., J. of Gen. Virol. (1987), vol. 68, pp. 2183-2192.
LaRocca Renato V.
Linehan W. Marston
Myers Charles E.
Stein Cy A.
Walther McClellan M.
Goldberg Jerome D.
The United States of America as represented by the Department of
LandOfFree
Suramin and active analogues thereof in the treatment of hyperca does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Suramin and active analogues thereof in the treatment of hyperca, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Suramin and active analogues thereof in the treatment of hyperca will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-975567